TrialReader


The Effects of Intermittent Hypoxia on Acute Hypoxic Injury

NCT05733338 — Not applicable, Unknown, 100 participants, Capital Medical University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT05733338
StatusUnknown
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: double, prevention
Enrollment100 (Estimated)
SponsorCapital Medical University (Other)
ConditionsAcute Mountain Sickness
InterventionsIntermittent Hypoxia, Sham Intermittent Hypoxia (Other)
Datesstart 2023-03-01, primary completion 2023-04-30 (estimated), completion 2023-04-30 (estimated), first posted 2023-02-17, last updated 2023-03-29
Locations1 site in China

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Acute Mountain Sickness All trials of Intermittent Hypoxia All trials of Sham Intermittent Hypoxia

-Summary

This study intends to further reveal the effectiveness of intermittent hypoxia in preventing acute hypoxic injury.

Expand all sections  ·  Collapse all

+Detailed description

Acute exposure to hypoxia can induce acute hypoxic injury (AHI), according to the severity of the injury, it can be divided into acute mountain sickness (AMS), high altitude pulmonary edema (HAPE) and high altitude cerebral edema (HACE). AMS is the most common type, it mostly occurs within 6-12 hours after rapidly entering the altitude above 2500m, sometimes within 1h, and can be manifested as headache, nausea, diarrhea, sleep disorders, etc. The incidence of AMS at the altitude of 2500-3000m is 10-20%, which reaches 50-85% at 4500-5000m above sea level.

Intermittent hypoxia (IH) refers to periodic hypoxic-normoxic training performed with brief exposure to hypoxia. Previous studies have found that short-term intermittent hypoxia can increase the sensitivity of hypoxia and reduce the severity of acute hypoxia injury, and alleviate acute hypoxia injury by reducing the inflammatory response caused by hypoxia. Therefore, this study aims to conduct a randomized controlled trial to further reveal the effectiveness of IH and explore its potential mechanisms.

+Arms and interventions

ArmTypeInterventionsDescription
IH groupActive comparatorOther: Intermittent HypoxiaParticipants will receive 10 times intermittent hypoxia (oxygen concentration: 13%) intervention before exposure to acute hypoxia environment.
Control groupSham comparatorOther: Sham Intermittent HypoxiaParticipants will receive 10 times sham-hypoxia (oxygen concentration: 21%) intervention in 5 days before exposure to acute hypoxia environment.
  • Intermittent Hypoxia (Other): The intermittent hypoxia protocol refers to four cycles of 10 minutes hypoxia inhaling interval by 5 minutes normoxia, which is performed twice a day (at least 6 hours apart) in 5 days.
  • Sham Intermittent Hypoxia (Other): The sham intermittent hypoxia protocol refers to 55 minutes normoxia inhaling, which is performed twice a day (at least 6 hours apart) in 5 days.

+Outcome measures

Primary outcomes

  • Incidence of acute mountain sickness between IH group and control group [After the 6-hour acute hypoxia exposuring.]: A questionnaire called 2018 Lake Louise Scoring System (LLSS) score \[0-12\] will be used in this primary outcome assessment. The higher LLS scores mean the worse symptoms of acute mountain sickness (AMS).

Secondary outcomes

  • Concentration of serum parameters between IH group and control group [After the 6-hour acute hypoxia exposuring.]
  • Incidence of intracranial hypertension between IH group and control group [After the 6-hour acute hypoxia exposuring.]: A noninvasive cranial pressure detector will be used to monitor the intracranial pressure.
  • Incidence of decreased reaction and executive ability between IH group and control group [After the 6-hour acute hypoxia exposuring.]: Related questionnaires will be used to assess the relevant cognitive domain.

+Eligibility

Sex: All, ages: 18 Years to 45 Years, accepts healthy volunteers

Inclusion Criteria:

* Informed written consent from the volunteers.
* Healthy volunteers between ages of 18 and 45 years, body mass index (BMI) of 19.0 and 24.9 kg/m2.
* Long-term residence at flatland (altitude of <100 m), not having been to an altitude ≥1500 m in 30 days.
* Resting peripheral oxygen saturation of more than 90%, cerebral oxygen saturation between 58%-82%, heart rate between 60 bpm and 100 bpm, and blood pressure within the normal range (90-130/60-80 mmHg).

Exclusion Criteria:

* History of cardiovascular, cerebrovascular, pulmonary, hepatic, dermatologic, or hematologic diseases.
* History of substance abuse.
* The use of medications or medical devices.
* Pregnancy, hypertension, diabetes mellitus, obesity, sleep apnea and neurological disorders.

+Locations (1)

FacilityCityCountryStatus
Xuanwu Hospital, Capital Medical UniversityBeijingChinaRecruiting

My Notes